(NasdaqGM:FOLD), PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ET Jefferies Global Healthcare Conference 2025 in London, […]
(NasdaqGM:ADAG), Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with KEYTRUDA with up to 30 patients per arm Company anticipates trial completion in early 2027, and
September 2025 Quarterly Activities Report GlobeNewswire October 31, 2025 QUEBEC CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) — West African gold producer and developer Robex Resources Inc. (“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Borse Frankfurt: RB4) is pleased to report on its activities for the September 2025 Quarter. Robex
Frozen Dessert Market Size to be Worth USD 198.20 Billion by 2034, Driven by Health Trends, Innovation, and Regional Growth According to Towards FnB, the global frozen dessert market size is calculated at USD 136.87 billion in 2025 and is anticipated to surge USD 198.20 billion by 2034, reflecting at a CAGR of 4.2% from
Dupixent(R) (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award GlobeNewswire October 31, 2025 Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions First and only therapy to specifically target the IL-4 and IL-13 signaling pathway, a key driver of type 2
Mesa Air Group enters into an Amendment to its Loan Agreement with the United States Treasury and Provides Update to its Pending Merger with Republic Airways GlobeNewswire October 31, 2025 US Treasury Loan Update PHOENIX, Oct. 31, 2025 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced that it
Falco Announces Extension of Its Senior Debts GlobeNewswire October 31, 2025 MONTREAL, Oct. 31, 2025 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation“) is pleased to announce that the Corporation has entered into binding agreements (i) with OR Royalties Inc. (“OR Royalties“) in order to extend the maturity date of the
Perspective Therapeutics to Participate in Upcoming November Conferences GlobeNewswire October 31, 2025 SEATTLE, Oct. 31, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be
Is the Rental Market finally Cooling? Canada's Rent Prices Dip as Immigration Slows Lower immigration levels ease rental pressures nationwide, while interprovincial migration reshapes regional market dynamics GlobeNewswire October 31, 2025 TORONTO and CALGARY, Alberta and EDMONTON, Alberta and MONTREAL and VANCOUVER, British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) — Canada's rental market is entering
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA(R) (pembrolizumab) in Microsatellite Stable Colorectal Cancer GlobeNewswire October 31, 2025 Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment